SLU-PP-332 CAPSULES
SLU-PP-332 is an experimental drug being studied as an “exercise mimetic” to treat metabolic diseases, primarily obesity, diabetes, and related conditions. It acts as an estrogen receptor-related orphan receptor (ERR) agonist, forcing the body to burn more fat and increase energy expenditure as if it were performing high-intensity exercise.
Key research areas for SLU-PP-332 include:
- Obesity and Weight Management: Studies show it can reduce fat mass in mice by over 10 times without altering food intake or requiring physical training.
- Metabolic Health: It improves insulin sensitivity and reduces fat accumulation, showing promise for treating metabolic syndrome.
- Muscle and Endurance Boost: It increases mitochondrial function and oxidative fibers in skeletal muscle, improving endurance.
- Cardioprotection: Research points to potential benefits in treating heart failure and protecting against kidney dysfunction.
